Gerresheimer completes Centor sale. Gerresheimer stock falls 1.93 percent

Published on 10/15/2026 at 10:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

LBBW lifted its target to EUR 29.00 on October 6, 2026. Gerresheimer stock costs EUR 28.91 on October 15, 2026, below the EUR 29.48 Xetra close.

Disposal and valuation context

Gerresheimer completed the Centor sale on October 1, 2026, directing proceeds toward debt reduction.
LBBW raised its target from EUR 28.00 to EUR 29.00 on October 6, 2026.
Gerresheimer stock trades at EUR 28.91 at 10:04 a.m. CEST at Lang & Schwarz on October 15, 2026, 1.93 percent below the Xetra close of October 14, 2026.
Second-quarter revenue was EUR 578.00 million and adjusted EBITDA was EUR 102.00 million in 2026.

Makroaufnahme der Oberflächenstruktur einer pharmazeutischen Glasampulle — Gerresheimer AG, ISIN DE000A0LD6E6, fertigt hochpräzises Pharmaglas, dessen feine Oberflächenstruktur diese Makroaufnahme eindrucksvoll zeigt, Illustration mit AI erstellt.

Gerresheimer stock (ISIN DE000A0LD6E6) was trading at EUR 28.91 at Lang & Schwarz on October 15, 2026 at 10:04 a.m. CEST, down 1.93 percent versus the Xetra close of October 14, 2026 (EUR 29.48). On October 1, 2026, FT.com reported that Gerresheimer had completed the Centor sale and would use the proceeds to reduce debt.

Centor sale changes debt path

The transaction was part of a combined EUR 1.50 billion enterprise value for Centor and the Primary Packaging Plastics business, with Centor accounting for half. The second disposal is expected in the first half of 2027, leaving debt reduction and refinancing as the next financial test.

Three dates reset the story

On July 29, 2026, Gerresheimer agreed to sell Centor and Primary Packaging Plastics for a combined EUR 1.50 billion, according to FT.com. On October 1, 2026, Centor was sold, and on October 6, 2026, Goldesel reported that LBBW raised its target from EUR 28.00 to EUR 29.00 while keeping a Hold rating.

What does the target say about valuation?

LBBW's EUR 29.00 target leaves limited room above the October 15 price. Gerresheimer's second-quarter 2026 revenue was EUR 578.00 million, down from EUR 614.00 million in the second quarter of 2025, while adjusted EBITDA was EUR 102.00 million versus EUR 126.00 million, according to Goldesel. The quarter-on-quarter improvement did not erase the year-over-year decline.

Next reporting date

Gerresheimer's next substantiated calendar item is the Berenberg European Conference on December 2, 2026, while the company investor page places its half-year financial report in November 2026. The Q3 2026 report is scheduled for December 2026, according to EQS News.

Stock below the Xetra close

The current quote sits EUR 0.57 below the October 14 Xetra close, making the disposal proceeds and operating recovery the key valuation reference points. Gerresheimer was trading at EUR 28.91 at Lang & Schwarz on October 15, 2026 at 10:04 a.m. CEST, 1.93 percent below the Xetra close of October 14, 2026 (EUR 29.48). The further course of trading is shown by the continuously updated real-time quote of Gerresheimer stock.